OrbiMed Advisors Israel II Ltd
CIK 0001682093 Name as filed on the most recent filing
Filed as OrbiMed Advisors Israel II Ltd (20)
70 transaction lines · from 20 filings · filed 2017-04-27 to 2026-04-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Adicet Bio, Inc. 4 filings
- ISSUER Upstream Bio, Inc. 1 filings
- ISSUER Galecto, Inc. 8 filings
- ISSUER 89bio, Inc. 3 filings
- ISSUER LogicBio Therapeutics, Inc. 2 filings
- ISSUER SteadyMed Ltd. 2 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-08 |
Adicet Bio, Inc. ACET |
S, Open-market sale | 40,416 disposed | 6.52 | 263,512.32 | Form 4, filing 0000947871-26-000421 | |
| 2026-04-08 |
Adicet Bio, Inc. ACET |
S, Open-market sale | 32,523 disposed | 6.29 | 204,569.67 | Form 4, filing 0000947871-26-000421 | |
| 2026-04-07 |
Adicet Bio, Inc. ACET |
S, Open-market sale | 29,319 disposed | 6.53 | 191,453.07 | Form 4, filing 0000947871-26-000421 | |
| 2026-04-07 |
Adicet Bio, Inc. ACET |
S, Open-market sale | 2,400 disposed | 6.38 | 15,312.00 | Form 4, filing 0000947871-26-000421 | |
| 2025-10-08 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 3,500,000 acquired | 1.00 | 3,500,000.00 | Form 4, filing 0000947871-25-000898 | |
| 2025-10-08 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 1,500,000 acquired | 1.00 | 1,500,000.00 | Form 4, filing 0000947871-25-000898 | |
| 2024-10-15 |
Upstream Bio, Inc. UPB |
P, Open-market purchase | 660,000 acquired | 17.00 | 11,220,000.00 | Form 4, filing 0000947871-24-000806 | |
| 2024-10-15 |
Upstream Bio, Inc. UPB |
P, Open-market purchase | 165,000 acquired | 17.00 | 2,805,000.00 | Form 4, filing 0000947871-24-000806 | |
| 2024-01-25 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 1,841,100 acquired | 2.40 | 4,418,640.00 | Form 4, filing 0000950170-24-008053 | |
| 2024-01-25 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 1,041,700 acquired | 2.40 | 2,500,080.00 | Form 4, filing 0000950170-24-008053 | |
| 2024-01-25 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 242,200 acquired | 2.40 | 581,280.00 | Form 4, filing 0000950170-24-008053 | |
| 2023-08-15 |
Galecto, Inc. GLTO |
S, Open-market sale | 535,534 disposed | 0.75 | 401,650.50 | Form 4, filing 0000947871-23-000873 | |
| 2023-08-15 |
Galecto, Inc. GLTO |
S, Open-market sale | 248,819 disposed | 0.75 | 186,614.25 | Form 4, filing 0000947871-23-000873 | |
| 2023-08-15 |
Galecto, Inc. GLTO |
S, Open-market sale | 38,327 disposed | 0.75 | 28,745.25 | Form 4, filing 0000947871-23-000873 | |
| 2023-07-31 |
Galecto, Inc. GLTO |
S, Open-market sale | 153,078 disposed | 3.00 | 459,234.00 | Form 4, filing 0000947871-23-000809 | |
| 2023-07-31 |
Galecto, Inc. GLTO |
S, Open-market sale | 29,700 disposed | 3.00 | 89,100.00 | Form 4, filing 0000947871-23-000809 | |
| 2023-07-31 |
Galecto, Inc. GLTO |
S, Open-market sale | 26,622 disposed | 3.00 | 79,866.00 | Form 4, filing 0000947871-23-000809 | |
| 2023-07-25 |
Galecto, Inc. GLTO |
S, Open-market sale | 26,700 disposed | 2.92 | 77,964.00 | Form 4, filing 0000947871-23-000789 | |
| 2023-07-25 |
Galecto, Inc. GLTO |
S, Open-market sale | 7,800 disposed | 2.92 | 22,776.00 | Form 4, filing 0000947871-23-000789 | |
| 2023-07-25 |
Galecto, Inc. GLTO |
S, Open-market sale | 4,700 disposed | 2.92 | 13,724.00 | Form 4, filing 0000947871-23-000789 | |
| 2023-07-13 |
Galecto, Inc. GLTO |
S, Open-market sale | 132,100 disposed | 2.40 | 317,040.00 | Form 4, filing 0000947871-23-000753 | |
| 2023-07-13 |
Galecto, Inc. GLTO |
S, Open-market sale | 52,800 disposed | 2.40 | 126,720.00 | Form 4, filing 0000947871-23-000753 | |
| 2023-07-13 |
Galecto, Inc. GLTO |
S, Open-market sale | 9,800 disposed | 2.40 | 23,520.00 | Form 4, filing 0000947871-23-000753 | |
| 2023-06-27 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 442,000 acquired | 2.09 | 923,780.00 | Form 4, filing 0000947871-23-000713 | |
| 2023-06-27 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 250,000 acquired | 2.09 | 522,500.00 | Form 4, filing 0000947871-23-000713 | |
| 2023-06-27 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 125,000 acquired | 2.09 | 261,250.00 | Form 4, filing 0000947871-23-000713 | |
| 2023-06-27 |
Adicet Bio, Inc. ACET |
P, Open-market purchase | 58,000 acquired | 2.09 | 121,220.00 | Form 4, filing 0000947871-23-000713 | |
| 2023-04-17 |
Galecto, Inc. GLTO |
S, Open-market sale | 8,878 disposed | 1.97 | 17,489.66 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-17 |
Galecto, Inc. GLTO |
S, Open-market sale | 3,551 disposed | 1.97 | 6,995.47 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-17 |
Galecto, Inc. GLTO |
S, Open-market sale | 660 disposed | 1.97 | 1,300.20 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-14 |
Galecto, Inc. GLTO |
S, Open-market sale | 28,110 disposed | 1.86 | 52,284.60 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-14 |
Galecto, Inc. GLTO |
S, Open-market sale | 11,245 disposed | 1.86 | 20,915.70 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-14 |
Galecto, Inc. GLTO |
S, Open-market sale | 2,091 disposed | 1.86 | 3,889.26 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-13 |
Galecto, Inc. GLTO |
S, Open-market sale | 9,459 disposed | 1.82 | 17,215.38 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-13 |
Galecto, Inc. GLTO |
S, Open-market sale | 3,784 disposed | 1.82 | 6,886.88 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-13 |
Galecto, Inc. GLTO |
S, Open-market sale | 703 disposed | 1.82 | 1,279.46 | Form 4, filing 0000947871-23-000472 | |
| 2023-04-12 |
Galecto, Inc. GLTO |
S, Open-market sale | 1,603 disposed | 1.81 | 2,901.43 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-12 |
Galecto, Inc. GLTO |
S, Open-market sale | 641 disposed | 1.81 | 1,160.21 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-12 |
Galecto, Inc. GLTO |
S, Open-market sale | 119 disposed | 1.81 | 215.39 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-11 |
Galecto, Inc. GLTO |
S, Open-market sale | 9,459 disposed | 1.82 | 17,215.38 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-11 |
Galecto, Inc. GLTO |
S, Open-market sale | 3,784 disposed | 1.82 | 6,886.88 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-11 |
Galecto, Inc. GLTO |
S, Open-market sale | 703 disposed | 1.82 | 1,279.46 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-10 |
Galecto, Inc. GLTO |
S, Open-market sale | 34,745 disposed | 1.79 | 62,193.55 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-10 |
Galecto, Inc. GLTO |
S, Open-market sale | 13,899 disposed | 1.79 | 24,879.21 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-10 |
Galecto, Inc. GLTO |
S, Open-market sale | 2,584 disposed | 1.79 | 4,625.36 | Form 4, filing 0000947871-23-000452 | |
| 2023-04-06 |
Galecto, Inc. GLTO |
S, Open-market sale | 6,558 disposed | 2.00 | 13,116.00 | Form 4, filing 0000947871-23-000438 | |
| 2023-04-06 |
Galecto, Inc. GLTO |
S, Open-market sale | 2,620 disposed | 2.00 | 5,240.00 | Form 4, filing 0000947871-23-000438 | |
| 2023-04-06 |
Galecto, Inc. GLTO |
S, Open-market sale | 487 disposed | 2.00 | 974.00 | Form 4, filing 0000947871-23-000438 | |
| 2023-04-05 |
Galecto, Inc. GLTO |
S, Open-market sale | 63,058 disposed | 2.18 | 137,466.44 | Form 4, filing 0000947871-23-000438 | |
| 2023-04-05 |
Galecto, Inc. GLTO |
S, Open-market sale | 25,220 disposed | 2.18 | 54,979.60 | Form 4, filing 0000947871-23-000438 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. OrbiMed Advisors Israel II Ltd, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001682093
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6